Liver Metastases Do Not Predict Resistance to the Addition of Atezolizumab to First-Line FOLFOXIRI Plus Bevacizumab in Proficient MMR Metastatic Colorectal Cancer: a Secondary Analysis of the AtezoTRIBE Study.
ESMO open(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined